Agency information collection activities: Submission for OMB review; comment request,

[Federal Register: March 18, 1998 (Volume 63, Number 52)]

[Notices]

[Page 13270]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr18mr98-105]

[[Page 13270]]

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Agency Information Collection Activities: Extension of Existing Collection; Comment Request

ACTION: Notice of information collection under review; Application for procurement quota for controlled substances.

Office of Management and Budget approval is being sought for the information collection listed below. This proposed information collection was previously published in the Federal Register on December 30, 1997 at 62 FR 67901, allowing for a 60-day public comment period.

The purpose of this notice is to allow an additional 30 days for public comments until April 17, 1998. This process is conducted in accordance with 5 CFR 1320.10.

Written comments and/or suggestions regrading the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Regulatory Affairs, Attention: Department of Justice Desk Office, Washington, DC 20530. Additionally, comments may be submitted to OMB via facsimile to (202) 395-7285. Comments may also be submitted to the Department of Justice (DOJ), Justice Management Division, Information Management and Security Staff, Attention: Department Clearance Officer, Suite 850, 1101 G Street, NW, Washington, DC 20530. Additionally, comments may be submitted to DOJ via facsimile to (202) 514-1590.

Written comments and suggestions from the public and affected agencies concerning the proposed collection of information should address one or more of the following four points:

1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;

2. Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;

3. Enhance the quality, utility, and clarity of the information to be collected; and

4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses.

   Overview of the information collection:

1. Type of Information Collection: Extension of previously approved collection.

2. Title of the Form/Collection: Application for Procurement Quota for Controlled Substances.

3. Agency form number: DEA Form 250, if any, and the applicable component of the Department of Justice sponsoring the collection: Office of Diversion Control, Drug Enforcement Administration, Department of Justice.

4. Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other for-profit.

   Title 21, Section 1303.12, requires U.S. companies involved in the manufacture of dosage forms or into other substances of Schedule I or II controlled substances must apply on DEA Form 250 each year for assignment of their quota of a specific Schedule I or II controlled substance.

5. An estimate of the total estimated number of respondents and the amount of time estimated for an average respondent to respond: 531 respondents at 1 response per year at 1 hour per response.

6. An estimate of the total public burden (in hours) associated with the collection: 531 annual burden hours.

   If additional information is required contact: Mr. Robert B. Briggs, Clearance Officer, United States Department of Justice, Information Management and Security Staff, Justice Management Division, Suite 850, Washington Center, 1001 G Street, NW, Washington, DC 20530.

   Dated: March 12, 1998. Robert B. Briggs, Department Clearance Officer, United States Department of Justice.

   [FR Doc. 98-6962Filed3-17-98; 8:45 am]

   BILLING CODE 4410-09-M